NDC 42291-018

AMBRISENTAN

Ambrisentan

AMBRISENTAN is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Avkare. The primary component is Ambrisentan.

Product ID42291-018_b6c019e2-3f31-061d-e053-2a95a90a89d3
NDC42291-018
Product TypeHuman Prescription Drug
Proprietary NameAMBRISENTAN
Generic NameAmbrisentan
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-12-18
Marketing CategoryANDA / ANDA
Application NumberANDA208354
Labeler NameAvKARE
Substance NameAMBRISENTAN
Active Ingredient Strength5 mg/1
Pharm ClassesEndothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 42291-018-30

30 TABLET, FILM COATED in 1 BOTTLE (42291-018-30)
Marketing Start Date2020-12-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "AMBRISENTAN" or generic name "Ambrisentan"

NDCBrand NameGeneric Name
0378-4270Ambrisentanambrisentan
0378-4271Ambrisentanambrisentan
0591-2405AmbrisentanAmbrisentan
0591-2406AmbrisentanAmbrisentan
42291-018AMBRISENTANAMBRISENTAN
42291-019AMBRISENTANAMBRISENTAN
42794-051AMBRISENTANAMBRISENTAN
42794-052AMBRISENTANAMBRISENTAN
47335-236ambrisentanambrisentan
47335-237ambrisentanambrisentan
49884-353AmbrisentanAmbrisentan
49884-354AmbrisentanAmbrisentan
59651-494ambrisentanambrisentan
59651-495ambrisentanambrisentan
60505-4552AmbrisentanAMBRISENTAN
60505-4553AmbrisentanAMBRISENTAN
69097-386AmbrisentanAmbrisentan
69097-387AmbrisentanAmbrisentan
70710-1179AmbrisentanAmbrisentan
70710-1180AmbrisentanAmbrisentan
70771-1363AmbrisentanAmbrisentan
70771-1364AmbrisentanAmbrisentan
76282-684AmbrisentanAmbrisentan
76282-685AmbrisentanAmbrisentan
61958-0801LetairisAMBRISENTAN
61958-0802LetairisAMBRISENTAN

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.